Laparascopy Versus Laparatomy in the Management of Ruptured Ectopic Pregnancy
A RANDOMISED TRIAL COMPARING LAPARASCOPY VERSUS LAPAROTOMY IN THE MANAGEMENT OF WOMEN DIAGNOSED WITH ECTOPIC PREGNANCY
1 other identifier
interventional
140
1 country
1
Brief Summary
Standard management for patients with ruptured ectopic pregnancies at our institution is treatment by laparotomy. This trail will investigate the feasibility of treatment with laparoscopy and will look at outcomes such as hospital stay and pain experienced The hypothesis is that laparoscopy is a feasible treatment option associated with shorter hospital stay and less pain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2012
CompletedFirst Submitted
Initial submission to the registry
August 27, 2013
CompletedFirst Posted
Study publicly available on registry
August 30, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2013
CompletedMarch 11, 2021
March 1, 2021
1.5 years
August 27, 2013
March 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospital stay
Hospital stay will be compared between the two groups
5 days
Secondary Outcomes (2)
Pain scores
24 hours
Theatre time
1 day
Study Arms (2)
Laparotomy arm
OTHERStandard treatment
Laparoscopy arm
EXPERIMENTALTreatment by laparoscopy
Interventions
Laparotomy as standard treatment for ruptured ectopic pregnancy
Eligibility Criteria
You may qualify if:
- Age \>18 years
- Able to give informed consent
- must have two of the following three:
- systolic blood pressure \>90 mmHg
- pulse rate \<100 beats per minute
- heamoglobin \>8 g/dL
You may not qualify if:
- \<18 years
- haemodynamically unstable
- not able to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kalafong Academic Hospital
Pretoria, Gauteng, 0001, South Africa
Study Officials
- PRINCIPAL INVESTIGATOR
Leon C Snyman, MBChB FCOG
Principal Specialist, Department Obstetrics & Gynaecology, University of Pretoria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 27, 2013
First Posted
August 30, 2013
Study Start
May 2, 2012
Primary Completion
October 31, 2013
Study Completion
November 30, 2013
Last Updated
March 11, 2021
Record last verified: 2021-03